New oxygen method may reduce risks during heart valve procedure
NCT ID NCT07059728
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 31 times
Summary
This study tests whether high-flow nasal oxygen can prevent low oxygen levels and breathing complications in patients undergoing a minimally invasive heart valve replacement (TAVR). About 452 adults having elective TAVR will receive either high-flow oxygen or standard oxygen during sedation. The goal is to see if high-flow oxygen reduces complications like hospital readmission, stroke, or kidney injury within 30 days after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS TREATED WITH TAVI are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clinic de Barcelona
RECRUITINGBarcelona, Barcelona, 08036, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.